The 7th International Conference on Pharmaceutics and Novel Drug Delivery System, is a premier global platform that brings together researchers, scientists, clinicians, industry experts, and innovators to explore the latest advancements in drug formulation, delivery technologies, and translational research. This conference focuses on cutting-edge strategies to enhance drug efficacy, safety, and patient compliance, including targeted delivery systems, controlled release platforms, nanocarriers, biologics, and vaccine formulations.
Participants will gain insights into emerging trends, such as smart and stimuli-responsive delivery systems, personalized medicine, and AI-driven formulation design, as well as regulatory considerations for novel therapeutics. The event provides opportunities for presenting research, engaging in interactive workshops, and networking with leading experts to foster collaborations that accelerate the development and clinical translation of next-generation therapies.
This two-day event aims to bridge the gap between academic research and practical applications, focusing on the latest advancements in novel drug delivery systems, pharmaceutics, nanotechnology-based formulations, targeted therapeutics, sustained-release systems, and regulatory frameworks. Participants will have the opportunity to attend keynote lectures, plenary sessions, workshops, and interactive poster presentations, offering rich insights into emerging trends, challenges, and innovations in the field.
KEY HIGHLIGHTS:
VISA ASSISTANCE:
PARTICIPATION BENEFITS:
Present and Shine
Showcase your research, case studies, or innovative drug delivery systems to a global audience.
Gain recognition from leading experts in pharmaceutics, pharmaceutical sciences, and drug delivery technologies.
Receive constructive feedback to enhance the impact and applicability of your work.
Learn from Experts
Attend keynote sessions and plenary lectures by internationally renowned pharmaceutical scientists and innovators.
Engage in interactive workshops that deepen your understanding of emerging drug delivery strategies, formulations, and regulatory considerations.
Stay updated on the latest evidence-based practices, breakthrough technologies, and innovations in pharmaceutics.
Collaborate and Network
Connect with researchers, industry professionals, clinicians, and academic leaders worldwide.
Build collaborations for future research, clinical trials, or industrial partnerships.
Expand your professional network and discover global opportunities in drug development and novel therapeutics.
Hands-On Skill Development
Participate in practical sessions designed to enhance your formulation, analytical, and clinical research expertise.
Gain insights into real-world applications of innovative drug delivery systems and pharmaceutical interventions.
Strengthen your professional skills for both laboratory research and translational applications.
Discover Innovations
Explore cutting-edge technologies in nanoformulations, targeted drug delivery, and controlled release systems.
Learn about emerging trends that are revolutionizing pharmaceutical sciences and patient care.
Understand how innovative strategies can be applied across diverse therapeutic areas.
Professional Growth
Access mentorship, awards, and certification opportunities that advance your career in pharmaceutics and drug delivery research.
Enhance your visibility within the global pharmaceutical and scientific community.
Gain recognition for your contributions to pharmaceutical innovation and drug delivery science.
Influence the Future
Contribute to shaping pharmaceutical practices, policies, and global healthcare strategies.
Engage in discussions that drive meaningful change in drug delivery, patient care, and therapeutic innovation.
Be part of initiatives that impact the future of pharmaceutics and novel drug delivery research.
SESSION AND TRACKS:
Track 1: Novel Drug Delivery Systems
This track focuses on cutting-edge platforms for delivering drugs effectively and safely. It covers innovative carriers like nanoparticles, liposomes, micelles, dendrimers, and polymeric systems, with an emphasis on enhancing bioavailability, targeted delivery, and controlled release. Discussions will explore how these systems can optimize therapeutic outcomes and minimize side effects across multiple disease areas.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 2: Advanced Formulation Technologies
Sessions under this track will discuss modern approaches to formulating small molecules, biologics, and vaccines. Emphasis will be on improving stability, solubility, and therapeutic efficacy. Novel techniques such as nanoformulations, solid dispersions, emulsions, and lyophilisation will be explored along with their translational potential.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 3: Biopharmaceutics & Pharmacokinetics
This track highlights the interplay between drug formulation and pharmacokinetics, focusing on absorption, distribution, metabolism, and excretion (ADME). Attendees will learn how advanced formulation strategies can influence bioavailability and therapeutic efficacy, with sessions on PK/PD modeling and biopharmaceutical studies.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 4: Targeted & Precision Medicine
Focuses on personalized approaches to drug delivery that tailor therapy to individual patient profiles or specific disease states. Sessions include tumor-targeted therapeutics, organ-specific delivery systems, antibody-drug conjugates, and gene therapy vectors, highlighting how precision medicine is revolutionizing treatment paradigms.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 5: Nanotechnology in Drug Delivery
This track explores nanoscale drug carriers and the role of nanotechnology in improving therapeutic outcomes. Sessions cover surface-engineered nanoparticles, quantum dots, nanorobots, and stimuli-responsive systems designed for controlled and targeted delivery, bridging nanoscience with clinical application.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 6: Controlled & Sustained Release Systems
This track addresses systems that deliver drugs at predetermined rates to maintain therapeutic concentrations over time. Sessions include hydrogels, matrix systems, implantable devices, oral and injectable depot formulations, highlighting design principles, clinical benefits, and translational applications.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 7: Pharmaceutical Biotechnology
Focuses on the development, formulation, and delivery of biologics including proteins, peptides, monoclonal antibodies, and nucleic acid therapeutics. Sessions explore stability, bioavailability, delivery challenges, and emerging strategies for efficient therapeutic administration.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 8: Regulatory & Quality Aspects
This track emphasizes regulatory compliance, quality control, and guidelines for approval of novel drug delivery systems. Discussions include FDA and EMA requirements, GMP practices, risk assessment, and quality by design (QbD) to ensure safe and effective pharmaceutical products.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 9: Drug Discovery & Translational Research
Sessions focus on the journey from preclinical drug discovery to clinical translation. Topics include lead optimization, high-throughput screening, animal models, and translational pharmacology, aiming to accelerate bench-to-bedside research.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 10: Oral & Gastrointestinal Delivery Systems
This track explores strategies for enhancing oral bioavailability and protecting drugs in the gastrointestinal environment. Sessions cover enteric coatings, mucoadhesive systems, solubility enhancement, and nanocarriers designed for GI targeting.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 11: Injectable & Parenteral Delivery Systems
Focuses on intravenous, subcutaneous, and intramuscular delivery of drugs with sustained or targeted action. Discussions cover liposomal formulations, injectable depots, micro-needle systems, biocompatibility, and sterilization techniques.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 12: Pulmonary & Nasal Drug Delivery
Covers inhalation and intranasal systems for local or systemic therapy. Sessions highlight aerosol engineering, dry powder inhalers, nasal sprays, and device optimization for effective pulmonary delivery and patient compliance.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 13: Transdermal & Topical Delivery Systems
Focuses on skin-targeted formulations including patches, gels, and creams for local or systemic effects. Emphasis is placed on penetration enhancers, microneedles, patient compliance, and therapeutic efficacy.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 14: Vaccine Formulations & Delivery Technologies
Explores novel vaccine platforms and delivery strategies to improve immunogenicity. Sessions include mRNA vaccines, viral vectors, nanoparticle vaccines, adjuvants, and cold chain innovations for global distribution.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 15: Drug Delivery in Oncology
Highlights targeted therapies and smart delivery systems for cancer treatment. Sessions include tumor-specific carriers, combination approaches, nano-oncology innovations, immunotherapy delivery, and precision oncology strategies.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 16: Biodegradable & Stimuli-Responsive Systems
Focuses on polymers, hydrogels, and carriers that respond to external stimuli such as pH, temperature, or enzymes, ensuring controlled drug release and biodegradability. Applications in regenerative medicine and chronic disease treatment are discussed.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 17: Brain & CNS Drug Delivery
Covers strategies to overcome the blood–brain barrier for effective CNS therapy. Sessions include intranasal delivery, nanoparticle carriers, and formulation innovations for neurodegenerative diseases and neurological disorders.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 18: Imaging, Diagnostics & Theranostics
This track integrates drug delivery with imaging and diagnostic technologies for personalized therapy. Sessions explore theranostic nanoparticles, molecular imaging, contrast agents, and real-time monitoring of therapeutic response.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 19: Industrial Perspectives & Commercialization
Focuses on scaling up novel drug delivery systems, technology transfer, manufacturing, and market trends. Case studies highlight successful translation of research into commercial pharmaceutical products.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
Track 20: Future Trends & Emerging Innovations
Explores next-generation delivery systems, AI-driven formulation design, 3D-printed therapeutics, and futuristic approaches in personalized medicine. Sessions provide insight into upcoming innovations shaping the future of pharmaceutics.
Novel Drug Delivery Systems (NDDS) | Advanced Pharmaceutics | Controlled & Targeted Drug Delivery | Nano formulations | Nano carriers | Liposomal & Polymeric Drug Delivery | Oral Controlled Release | Solubility Enhancement | Gastrointestinal Targeting | Injectable & Implantable Drug Delivery | Long-Acting Formulations |Transdermal Drug Delivery | Microneedles | Topical & Permeation Technologies | Pulmonary & Nasal Drug Delivery | Drug–Device Combinations
MARKET ANALYSIS REPORT:
The global novel drug delivery systems (NDDS) market is experiencing strong growth driven by increasing demand for advanced therapies that improve drug efficacy, safety, and patient adherence. Recent industry estimates project the NDDS market to grow from approximately $106.95 billion in 2024 to $117.66 billion in 2025 at a robust compound annual growth rate (CAGR) of around 10 %, reflecting rising prevalence of chronic diseases, ageing populations, and growing demand for minimally invasive treatments. Continued expansion is expected through the end of the decade, with forecasts suggesting the market will reach around $171 billion by 2029, maintaining near‑double‑digit CAGR growth.
Analyst insights indicate that drivers such as the increasing adoption of targeted delivery platforms, controlled release systems, biologics formulation innovations, and advanced carrier technologies like nanoparticles and smart delivery devices are reshaping the pharmaceutical landscape. Geographically, North America continues to dominate the NDDS segment due to high R&D investment, mature regulatory infrastructure, and rapid adoption of novel therapies, followed by strong growth potential in Europe and the Asia‑Pacific region, where expanding healthcare access and increasing biotech manufacturing are key supportive factors.
Advanced Market Trends
Beyond size and growth estimates, the drug delivery market as a whole—when considered with formulation, devices, and technologies—is projected to expand into the hundreds of billions of dollars, reflecting increased investment across biologics/large‑molecule delivery, long‑acting injectables, targeted nanotechnology delivery, and device‑formulation combination products. Trends such as AI‑enabled formulation design, personalized medicine, and wearable/connected delivery solutions are also accelerating development and commercial interest.
Conference Evolution and Impact
Previous iterations of this conference series have also highlighted innovation in pharmaceutics, nanotechnology integration, and clinical translation of novel drug delivery solutions. For example, editions held in 2023 and earlier emphasized global industry participation and multidisciplinary exchange, reflecting ongoing growth in both scientific output and commercial interest in drug delivery advances. Industry leaders and academic researchers routinely use these conferences to disseminate new findings, discuss regulatory pathways, and explore collaborative opportunities that expedite next‑generation therapeutics from concept to clinical impact.
Key Takeaways
Overall, the novel drug delivery systems market represents a rapidly evolving and highly strategic segment within the broader pharmaceutical industry. Its sustained growth is driven by demographic trends, chronic disease burdens, technological innovation, and a global push toward precision and patient‑centric therapies. Conferences like PDDS play a vital role in catalyzing scientific progress, enhancing cross‑sector collaboration, and accelerating real‑world impact